SVF Investments (UK) Ltd's Net Worth
$0
Estimate Recalculated Nov 11, 2024 08:52AM EST
Who is SVF Investments (UK) Ltd?
SVF Investments (UK) Ltd does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Sciences Ltd., and Coupang, Inc..
SEC CIK
SVF Investments (UK) Ltd's CIK is 0001716729
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Coupang, Inc. (CPNG) Snapshot price: $22.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.77% | -46.61M |
$19.20 | -$894,927,187.28 | 349.54M |
Mar 12 - Mar 13
| |||
Form 4
| -7.04% | -30.00M |
$15.39 | -$461,700,000.00 | 396.16M |
Nov 29
| |||
Form 4
| -7.59% | -35.00M |
$18.50 | -$647,500,000.00 | 426.16M |
Dec 5
| |||
Form 4
| -9.78% | -50.00M |
$20.87 | -$1,043,500,000.00 | 461.16M |
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -9.12% | -57.00M |
$29.69 | -$1,692,045,000.00 | 568.16M |
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.04% | -10.00M |
$12.60 | -$126,000,000.00 | 73.03M |
Sep 28
| |||
Form 4
| -12.63% | -12.00M |
$8.00 | -$96,000,000.00 | 83.03M |
Mar 20
| |||
Form 4
| -4.37% | -4.34M |
$4.75 | -$20,633,615.25 | 95.03M |
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.02% | 14.48K |
$7.64 | $110,461.18 | 68.24M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.10% | 21.61K |
$7.54 | $162,875.90 | 22.73M |
May 16 - May 20
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||